A small-molecule inhibitor of integrin alpha2 beta1 introduces a new strategy for antithrombotic therapy.
Nissinen L, Pentikäinen OT, Jouppila A, Käpylä J, Ojala M, Nieminen J, Lipsanen A, Lappalainen H, Eckes B, Johnson MS, Lassila R, Marjamäki A, Heino J.
Nissinen L, et al. Among authors: jouppila a.
Thromb Haemost. 2010 Feb;103(2):387-97. doi: 10.1160/TH09-06-0358. Epub 2009 Dec 1.
Thromb Haemost. 2010.
PMID: 20126829